Literature DB >> 21167246

APOBEC3H haplotypes and HIV-1 pro-viral vif DNA sequence diversity in early untreated human immunodeficiency virus-1 infection.

P A Gourraud1, A Karaouni, J M Woo, T Schmidt, J R Oksenberg, F M Hecht, T J Liegler, J D Barbour.   

Abstract

We examined single nucleotide polymorphisms (SNP) in the APOBEC3 locus on chromosome 22, paired with population sequences of pro-viral human immunodeficiency virus-1 (HIV-1) vif from peripheral blood mononuclear cells, from 96 recently HIV-1-infected treatment-naive adults. We found evidence for the existence of an APOBEC3H linkage disequilibrium (LD) block associated with variation in GA → AA, or APOBEC3F/H signature, sequence changes in pro-viral HIV-1 vif sequence (top 10 significant SNPs with a significant p = 4.8 × 10(-3)). We identified a common five position risk haplotype distal to APOBEC3H (A3Hrh). These markers were in high LD (D' = 1; r(2) = 0.98) to a previously described A3H "RED" haplotype containing a variant (E121) with enhanced susceptibility to HIV-1 Vif. This association was confirmed by a haplotype analysis. Homozygote carriers of the A3Hrh had lower GA->AA (A3F/H) sequence editing upon pro-viral HIV-1 vif sequence (p = 0.01), and lower HIV-1 RNA levels over time during early, untreated HIV-1 infection, (p = 0.015 mixed effects model). This effect may be due to enhanced susceptibility of A3H forms to HIV-1 Vif mediated viral suppression of sequence editing activity, slowing viral diversification and escape from immune responses.
Copyright © 2011 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21167246      PMCID: PMC3039048          DOI: 10.1016/j.humimm.2010.12.008

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  25 in total

1.  Handling missing values in population data: consequences for maximum likelihood estimation of haplotype frequencies.

Authors:  Pierre-Antoine Gourraud; Emmanuelle Génin; Anne Cambon-Thomsen
Journal:  Eur J Hum Genet       Date:  2004-10       Impact factor: 4.246

2.  Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.

Authors:  Qin Yu; Renate König; Satish Pillai; Kristopher Chiles; Mary Kearney; Sarah Palmer; Douglas Richman; John M Coffin; Nathaniel R Landau
Journal:  Nat Struct Mol Biol       Date:  2004-04-18       Impact factor: 15.369

3.  PLINK: a tool set for whole-genome association and population-based linkage analyses.

Authors:  Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham
Journal:  Am J Hum Genet       Date:  2007-07-25       Impact factor: 11.025

4.  The Babel Tower revisited: SNPs - Indels - CNVs. Confusion in naming sequence variant always rises from ashes.

Authors:  P A Gourraud; M Feolo
Journal:  Tissue Antigens       Date:  2009-12-20

5.  Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.

Authors:  Molly OhAinle; Julie A Kerns; Harmit S Malik; Michael Emerman
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

6.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

7.  Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication.

Authors:  Yong-Hui Zheng; Dan Irwin; Takeshi Kurosu; Kenzo Tokunaga; Tetsutaro Sata; B Matija Peterlin
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

8.  Persistence of primary drug resistance among recently HIV-1 infected adults.

Authors:  Jason D Barbour; Frederick M Hecht; Terri Wrin; Teri J Liegler; Clarissa A Ramstead; Michael P Busch; Mark R Segal; Christos J Petropoulos; Robert M Grant
Journal:  AIDS       Date:  2004-08-20       Impact factor: 4.177

9.  Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection.

Authors:  Jason D Barbour; Frederick M Hecht; Terri Wrin; Mark R Segal; Clarissa A Ramstead; Teri J Liegler; Michael P Busch; Christos J Petropoulos; Nicholas S Hellmann; James O Kahn; Robert M Grant
Journal:  J Infect Dis       Date:  2004-06-18       Impact factor: 5.226

10.  The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.

Authors:  Ann M Sheehy; Nathan C Gaddis; Michael H Malim
Journal:  Nat Med       Date:  2003-10-05       Impact factor: 53.440

View more
  17 in total

1.  The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.

Authors:  Mawuena Binka; Marcel Ooms; Myeika Steward; Viviana Simon
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

2.  Polymorphism in human APOBEC3H affects a phenotype dominant for subcellular localization and antiviral activity.

Authors:  Melody M H Li; Michael Emerman
Journal:  J Virol       Date:  2011-06-08       Impact factor: 5.103

3.  APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages.

Authors:  Chawaree Chaipan; Jessica L Smith; Wei-Shau Hu; Vinay K Pathak
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

4.  Expression of APOBEC3G/3F and G-to-A hypermutation levels in HIV-1-infected children with different profiles of disease progression.

Authors:  Nívea D Amoêdo; Adriana O Afonso; Sílvia M Cunha; Ricardo H Oliveira; Elizabeth S Machado; Marcelo A Soares
Journal:  PLoS One       Date:  2011-08-29       Impact factor: 3.240

5.  APOBEC3 versus Retroviruses, Immunity versus Invasion: Clash of the Titans.

Authors:  Ann M Sheehy; Julie Erthal
Journal:  Mol Biol Int       Date:  2012-06-06

6.  New infections and HIV-1 subtypes among febrile persons and blood donors in Oyo State, Nigeria.

Authors:  Babatunde A Olusola; David O Olaleye; Georgina N Odaibo
Journal:  J Med Virol       Date:  2021-03-01       Impact factor: 20.693

Review 7.  Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein.

Authors:  Carsten Münk; Björn-Erik O Jensen; Jörg Zielonka; Dieter Häussinger; Christel Kamp
Journal:  Viruses       Date:  2012-11-14       Impact factor: 5.048

8.  The resistance of human APOBEC3H to HIV-1 NL4-3 molecular clone is determined by a single amino acid in Vif.

Authors:  Marcel Ooms; Michael Letko; Mawuena Binka; Viviana Simon
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

9.  Reduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities.

Authors:  Anjie Zhen; Juan Du; Xiaohong Zhou; Yong Xiong; Xiao-Fang Yu
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

10.  Lower HIV provirus levels are associated with more APOBEC3G protein in blood resting memory CD4+ T lymphocytes of controllers in vivo.

Authors:  Mariapia De Pasquale; Yordanka Kourteva; Tara Allos; Richard T D'Aquila
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.